Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study

Fecha de publicación: Fecha Ahead of Print:

Autores de I3PT

Participantes ajenos a I3PT

  • Rouze, A
  • Povoa, P
  • Makris, D
  • Bouchereau, M
  • Lambiotte, F
  • Metzelard, M
  • Cuchet, P
  • Geronimi, CB
  • Labruyere, M
  • Tamion, F
  • Nyunga, M
  • Luyt, CE
  • Labreuche, J
  • Pouly, O
  • Bardin, J
  • Saade, A
  • Asfar, P
  • Baudel, JL
  • Beurton, A
  • Garot, D
  • Ioannidou, I
  • Kreitmann, L
  • Llitjos, JF
  • Magira, E
  • Megarbane, B
  • Meguerditchian, D
  • Mekontso-Dessap, A
  • Reignier, J
  • Turpin, M
  • Pierre, A
  • Plantefeve, G
  • Vinsonneau, C
  • Floch, PE
  • Weiss, N
  • Torres, A
  • Duhamel, A
  • Nseir, S
  • CoVAPid Study Grp

Grupos de Investigación

Abstract

Purpose Although patients with SARS-CoV-2 infection have several risk factors for ventilator-associated lower respiratory tract infections (VA-LRTI), the reported incidence of hospital-acquired infections is low. We aimed to determine the relationship between SARS-CoV-2 pneumonia, as compared to influenza pneumonia or no viral infection, and the incidence of VA-LRTI. Methods Multicenter retrospective European cohort performed in 36 ICUs. All adult patients receiving invasive mechanical ventilation > 48 h were eligible if they had: SARS-CoV-2 pneumonia, influenza pneumonia, or no viral infection at ICU admission. VA-LRTI, including ventilator-associated tracheobronchitis (VAT) and ventilator-associated pneumonia (VAP), were diagnosed using clinical, radiological and quantitative microbiological criteria. All VA-LRTI were prospectively identified, and chest-X rays were analyzed by at least two physicians. Cumulative incidence of first episodes of VA-LRTI was estimated using the Kalbfleisch and Prentice method, and compared using Fine-and Gray models. Results 1576 patients were included (568 in SARS-CoV-2, 482 in influenza, and 526 in no viral infection groups). VA-LRTI incidence was significantly higher in SARS-CoV-2 patients (287, 50.5%), as compared to influenza patients (146, 30.3%, adjusted sub hazard ratio (sHR) 1.60 (95% confidence interval (CI) 1.26 to 2.04)) or patients with no viral infection (133, 25.3%, adjusted sHR 1.7 (95% CI 1.2 to 2.39)). Gram-negative bacilli were responsible for a large proportion (82% to 89.7%) of VA-LRTI, mainly Pseudomonas aeruginosa, Enterobacter spp., and Klebsiella spp. Conclusions The incidence of VA-LRTI is significantly higher in patients with SARS-CoV-2 infection, as compared to patients with influenza pneumonia, or no viral infection after statistical adjustment, but residual confounding may still play a role in the effect estimates.

Datos de la publicación

ISSN/ISSNe:
0342-4642, 1432-1238

INTENSIVE CARE MEDICINE  SPRINGER

Tipo:
Article
Páginas:
188-198
PubMed:
33388794

Citas Recibidas en Web of Science: 260

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • SARS-CoV-2; COVID-19; Ventilator-associated pneumonia; Ventilator-associated tracheobronchitis; Critical illness

Campos de Estudio

Financiación

Cita

Compartir